tiprankstipranks
Advertisement
Advertisement

CRMD Stock Latest News

CorMedix Shareholders Reject Governance Changes at Annual Meeting
Company AnnouncementsCorMedix Shareholders Reject Governance Changes at Annual Meeting
8d ago
8K
CRMD
Federal Circuit Upholds CorMedix MINOCIN Patent Protection
PremiumCompany Announcements
Federal Circuit Upholds CorMedix MINOCIN Patent Protection
24d ago
8K
CRMD
CorMedix announces United States Court of Appeals affirms patent judgements
PremiumThe Fly
CorMedix announces United States Court of Appeals affirms patent judgements
24d ago
CRMD
Cormedix Earnings Call Highlights Surging Growth, New Risks
PremiumCompany Announcements
Cormedix Earnings Call Highlights Surging Growth, New Risks
1M ago
CRMD
Cormedix Earnings Call Highlights Growth, Raises Outlook
PremiumCompany Announcements
Cormedix Earnings Call Highlights Growth, Raises Outlook
2M ago
CRMD
Analyst Reiterates Buy on Cormedix, Maintains Unchanged $13 Price Target Amid Strengthening Commercial Execution and Pipeline Prospects
PremiumRatingsAnalyst Reiterates Buy on Cormedix, Maintains Unchanged $13 Price Target Amid Strengthening Commercial Execution and Pipeline Prospects
2M ago
CRMD
3 Low P/E Stocks with Over 40% Upside
Premium
Market News
3 Low P/E Stocks with Over 40% Upside
2M ago
CRMD
OPRA
CorMedix reports Q1 EPS 43c, consensus 33c
Premium
The Fly
CorMedix reports Q1 EPS 43c, consensus 33c
2M ago
CRMD
CorMedix raises FY26 revenue view to $325M-$345M from $300M-$320M
PremiumThe Fly
CorMedix raises FY26 revenue view to $325M-$345M from $300M-$320M
2M ago
CRMD
CRMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CRMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CRMD
3 Best Cheap Stocks Under $10 Worth Watching in May 2026
PremiumMarket News
3 Best Cheap Stocks Under $10 Worth Watching in May 2026
2M ago
ACHR
CRMD
Citizens healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Citizens healthcare analysts hold an analyst/industry conference call
2M ago
CRMD
CorMedix price target raised to $14 from $13 at RBC Capital
PremiumThe FlyCorMedix price target raised to $14 from $13 at RBC Capital
2M ago
CRMD
Buy Rating Reiterated on REZZAYO Trial Strength and Safety Profile; $13 Price Target Maintained
Premium
Ratings
Buy Rating Reiterated on REZZAYO Trial Strength and Safety Profile; $13 Price Target Maintained
2M ago
CRMD
CorMedix Reports Positive Phase III REZZAYO Prophylaxis Results
Premium
Company Announcements
CorMedix Reports Positive Phase III REZZAYO Prophylaxis Results
2M ago
8K
CRMD
CorMedix announces ReSPECT clinical trial met primary endpoint
PremiumThe Fly
CorMedix announces ReSPECT clinical trial met primary endpoint
2M ago
CRMD
3 ‘Strong Buy’ Low P/E Stocks with Over 40% Upside
PremiumMarket News
3 ‘Strong Buy’ Low P/E Stocks with Over 40% Upside
2M ago
GEO
CRMD
Cormedix: Undervalued Biotech with Differentiated Lead Asset and Attractive Risk‑Reward Justifying a Buy Rating
PremiumRatings
Cormedix: Undervalued Biotech with Differentiated Lead Asset and Attractive Risk‑Reward Justifying a Buy Rating
3M ago
CRMD
Cormedix Earnings Call: Peak DEFENCATH, Tough Road Ahead
PremiumCompany Announcements
Cormedix Earnings Call: Peak DEFENCATH, Tough Road Ahead
4M ago
CRMD
CorMedix Reaffirms DefenCath 2027 Sales and Outlook
PremiumCompany AnnouncementsCorMedix Reaffirms DefenCath 2027 Sales and Outlook
4M ago
8K
CRMD
CorMedix affirms FY26 revenue view of $300M-$320M, consensus $308.7M
Premium
The Fly
CorMedix affirms FY26 revenue view of $300M-$320M, consensus $308.7M
4M ago
CRMD
CorMedix price target lowered to $13 from $15 at Leerink
Premium
The Fly
CorMedix price target lowered to $13 from $15 at Leerink
4M ago
CRMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >